Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for associated production of a single top quark and W boson in pp collisions at sqrt[s]=7  TeV.

Physical review letters·2013
Same author

Observation of sequential Υ suppression in PbPb collisions.

Physical review letters·2013
Same author

Study of the Dijet mass spectrum in pp → W+jets events at sqrt[s] = 7 TeV.

Physical review letters·2013
Same author

Search for heavy neutrinos and W(R) bosons with right-handed couplings in a left-right symmetric model in pp collisions at sqrt[s]=7  TeV.

Physical review letters·2013
Same author

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV.

Physical review letters·2012
Same author

Measurement of the pseudorapidity and centrality dependence of the transverse energy density in Pb-Pb collisions at √(s(NN))=2.76 TeV.

Physical review letters·2012

Related Experiment Video

Updated: Jun 6, 2026

Temporomandibular Joint Pain Measurement by Bite Force and Von Frey Filament Assays in Mice
06:37

Temporomandibular Joint Pain Measurement by Bite Force and Von Frey Filament Assays in Mice

Published on: September 13, 2024

Risk management in clinical practice. Part 8. Temporomandibular disorders.

R Gray1, Z Al-Ani

  • 1Department of Dental Medicine and Surgery, University Hospital of Manchester, UK.

British Dental Journal
|November 13, 2010
PubMed
Summary
This summary is machine-generated.

Temporomandibular disorders (TMDs) can stem from various causes, including trauma, parafunction, disease, or dental work. This chapter emphasizes practitioner responsibility and risk management for patient and provider protection.

More Related Videos

Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents
09:05

Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents

Published on: January 10, 2014

Systematic Assessment of Mammalian Skull Specimens for Dental and Temporomandibular Joint Pathology
07:26

Systematic Assessment of Mammalian Skull Specimens for Dental and Temporomandibular Joint Pathology

Published on: August 22, 2022

Related Experiment Videos

Last Updated: Jun 6, 2026

Temporomandibular Joint Pain Measurement by Bite Force and Von Frey Filament Assays in Mice
06:37

Temporomandibular Joint Pain Measurement by Bite Force and Von Frey Filament Assays in Mice

Published on: September 13, 2024

Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents
09:05

Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents

Published on: January 10, 2014

Systematic Assessment of Mammalian Skull Specimens for Dental and Temporomandibular Joint Pathology
07:26

Systematic Assessment of Mammalian Skull Specimens for Dental and Temporomandibular Joint Pathology

Published on: August 22, 2022

Area of Science:

  • Dental Medicine
  • Oral Surgery
  • Maxillofacial Surgery

Background:

  • Temporomandibular disorders (TMDs) present with diverse etiologies.
  • Causes include idiopathic factors, macro/micro-trauma (e.g., parafunction), systemic diseases, and iatrogenic effects from dental procedures.

Purpose of the Study:

  • To inform practitioners about their responsibilities in managing TMDs.
  • To highlight the importance of meticulous record-keeping and risk mitigation strategies.

Main Methods:

  • This chapter provides guidelines and emphasizes best practices for practitioners.
  • Focuses on risk management and patient/practitioner protection.

Main Results:

  • Practitioners must be aware of their duties regardless of TMD origin.
  • Effective management hinges on precise documentation and proactive risk assessment.

Conclusions:

  • Adherence to guidelines ensures comprehensive care and safety for both patients and practitioners.
  • Proactive risk management is crucial in all temporomandibular disorder cases.